top of page

New Study Examines Barriers to Buprenorphine Access in Pharmacies

A study recently published in Drug and Alcohol Dependence examined barriers encountered by patients seeking to fill buprenorphine prescriptions from pharmacies in counties with high opioid-related mortality rates. Researchers conducted a telephone audit and analyzed availability across pharmacy type and county characteristics. Results of the study indicated that 73% of pharmacies contacted reported being able to dispense buprenorphine and 20% reported they would not distribute the medication. In addition, independent pharmacies and pharmacies in southern States were significantly more likely to restrict buprenorphine.Read more

5 views0 comments

Recent Posts

See All

SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.

bottom of page